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Dear Sirs,
We report the rare case of a primary angiitis of the CNS
(PACNS) with isolated spinal cord manifestation. This 44-
year-old female presented diffuse dysesthesia with mod-
erate progressive weakness of the lower limbs. There were
no cerebral symptoms; cMRI was normal. The diagnosis of
PACNS was made by a spinal cord biopsy demonstrating
granulomatous vasculitis. The patient was successfully
treated with steroids and methotrexate. During a 2 year
follow-up our patient did not show any brain or other organ
involvement.
The 44-year-old female presented with moderate pro-
gressive weakness of both legs and burning sensory
symptoms of all limbs and the trunk. In addition to mod-
erate paraparesis, the physical examination revealed a
moderate pallhypesthesia of the legs with reduced vibra-
tory sense and a diffuse hyp- and dysesthesia below the
level of CD5. The family history was unremarkable for
neurological diseases.
The MRI of the cervical spine showed a gadolinium-
enhancing lesion in the posterior part of the myelon with
intramedullary edema. This lesion extended from cervical
vertebral bodies 2–7 (Fig. 1a).
The cerebral MRI and visual evoked potentials were
entirely normal, the examination of the CSF revealed a
slight pleocytosis (12 cells/mm3), cytological examination
showed regular cells. Oligoclonal bands were absent which
makes multiple sclerosis highly improbable.
Laboratory examinations did not reveal any evidence for
either metabolic (vitamin-B12, folate), autoimmune or
infectious disorder. We found no aquaporin-4-antibodies.
With normal VEP, we had no evidence for neuromyelitis
optica.
We started with intravenous high dose methylpredniso-
lone therapy (1 g for 5 days), but symptoms relapsed after
3 months of disease freedom.
Before introduction of another immunosuppressive ther-
apy, and to exclude a spinal lymphoma, a biopsy of the spinal
lesion was taken. The neuropathological examination
revealed a granulomatous vasculitis with transmural
inflammation consisting of lymphocytes, epitheloid cells and
giant cells (Fig. 2a–h). There was no evidence for systemic
organ involvement assessed by thoracic and abdominal
computer tomography.
Treatment was started with methotrexate (20 mg/week)
combined with prednisolone (tapered from 80 to 10 mg/d
within 6 weeks).
Neurological examination at 3 month intervals revealed
normal findings except a slight dysesthesia in the legs.
A follow-up MRI after 24 months of treatment demon-
strated an obvious regression of the signal intensities within the
cervical cord (Fig. 1b), whereas the cMRI remained normal.
Spinal symptoms are a rare presentation of primary CNS
vasculitis [1]. The previously reported cases with spinal
cord involvement also showed progressive paraparesis and
dysesthesia as the most common clinical symptoms [2].
However, usually these symptoms occur in the course of
the disease and not at disease onset as in our case. A review
of the literature showed only eight cases with initially pure
spinal cord involvement [3]; half of these cases developed
brain lesions later on [1, 4].
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The stereotactic biopsy remains the gold standard
to assure the diagnosis of a CNS vasculitis [5], but the
diagnosis in daily clinical routine is often only based on
clinical and imaging findings as well as the response to
treatment. This might be a potential reason for overdiag-
nosing PACNS in clinical routine. As illustrated by our
case, histological verification is crucial for the diagnosis.
The standard therapy for PACNS consists of cortico-
steroids (1 mg/kg prednisolone) and pulsed cyclophos-
phamide (0.5 mg/kg). The treatment with cyclophospha
mide can have severe side effects [6]. Monotherapy with
steroids leads to higher recurrence rates [7]. Since metho-
trexate has been successfully used in systemic vasculitis
[8], we started treatment with a combination of steroids
and methotrexate. Our patient reached remission within
3 months and remains stable now more than 2 years later.
In biopsy-proven PACNS of the spinal cord, methotrexate
seems to be an effective and less toxic alternative to
cyclophosphamide.
Fig. 2 The histological features of primary spinal vasculitis. The
neuropathological examination revealed vascular thrombosis (a 1009
magnification, H&E staining) and vessel walls with transmural infiltra-
tion mainly consisting of several lymphocytes (b 2009 magnification,
H&E staining). In addition, there were epitheloid cells and giant cells
(c 4009 magnification, H&E staining) which are characteristic for
a granulomatous vasculitis. There was no evidence for demyelination
(d 2009 magnification, LFB-PAS staining). Immunostainings indicated
that the vessel walls were mainly infiltrated by CD3-positive T cells
(e 2009 magnification, immunohistochemistry for CD3) that were partly
CD8-positive cytotoxic T cells (f 2009 magnification, immunohisto-
chemistry for CD8). Furthermore, several CD68-positive macrophages
and activated microglial cells were detectable (g 2009 magnification,
immunohistochemistry for CD68). Within the CNS tissue, many reactive
astrocytes could be observed (h 2009 magnification, immunohisto-
chemistry for glial fibrillic acidic protein)
Fig. 1 a MR study of the untreated patient. Sagittal FSE T1-weighted
image shows a big, homogeneously enhancing lesion located in the cervical
cord. b Follow-up MR study 24 months later. Sagittal FSE T1-weighted
image shows no evidence of contrast enhancement of the cervical cord
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